Covinfo-all have to know about covid

  • Pravallika boodidha Department of Pharmacy Practice, Avanthi Institute of Pharmaceutical Sciences, Cherukupally, Vizayanagaram, Andhra Pradesh, India
  • L.Krishna Priya Department of Pharmacy Practice, Avanthi Institute of Pharmaceutical Sciences, Cherukupally, Vizayanagaram, Andhra Pradesh, India
  • B.Tushara Department of Pharmacy Practice, Avanthi Institute of Pharmaceutical Sciences, Cherukupally, Vizayanagaram, Andhra Pradesh, India
  • V.Swathi Priya Department of Pharmacy Practice, Avanthi Institute of Pharmaceutical Sciences, Cherukupally, Vizayanagaram, Andhra Pradesh, India
  • M.Sireesha Department of Pharmacy Practice, Avanthi Institute of Pharmaceutical Sciences, Cherukupally, Vizayanagaram, Andhra Pradesh, India
  • V.C.Randeep Raj Asst.profesor,Department of pharmacy practice, Avanthi institute of pharmaceutical sciences, Cherukupally, vizayanagaram, Andhra Pradesh, India.

Abstract

Coronavirus (COVID-19) is an enveloped RNA virus that's diversely found in humans and wildlife. a complete of 6 species are known to cause disease in humans. They are known to contaminate the neurological, respiratory, enteric, and hepatic systems. The past few decades have seen endemic outbreaks within the sort of Middle East respiratory syndrome coronavirus (MERS-CoV) and severe acute respiratory syndrome-related coronavirus (SARS-CoV). Yet again, we see the emergence of another eruption due to a replacement strain called the SARS-CoV-2 virus. As the number of cases continues to rise it's clear that these viruses pose a threatening effect on public health. This review will introduce a generally clear view of coronavirus and characterize the clinical features, evaluation, and treatment of infected patients. Currently, the diagnosis is acquired by the correlation between the positivity for COVID-19 genomic test and respiratory symptoms, reverse transcriptase-polymerase chain reaction (RT-PCR). Here, we abstracted the current known knowledge regarding epidemiological, pathology, clinical features, comorbidities, and treatment of COVID-19/ SARS-CoV-2 as recommendations for the control and safeguard of COVID-19.

Keywords: 2019-nCOV, SARS-CoV-2, COVID-19, Pneumonia, Anti virals, remdesivir.
Published
31/12/2022
Statistics
108 Views | 99 Downloads
Citatons
How to Cite
boodidha, P., L, K. P., B, T., V, S. P., M, S., & V, C. R. (2022). Covinfo-all have to know about covid. Journal of Case Studies and Case Reports, 1(3), 32-39. Retrieved from https://saapjournals.org/index.php/jcscr/article/view/389
Section
Review Articles